Low frequency repetitive transcranial magnetic stimulation (rTMS) for Alcoholism

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
AlcoholismLow frequency repetitive transcranial magnetic stimulation (rTMS) - Device
Eligibility
21 - 35
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether a single session of rTMS can reduce the amount of alcohol consumed during a self-administration session. 20 people who report binge drinking will be enrolled and randomly assigned to have either rTMS or a sham session. They will then have the opposite intervention 7-14 days later.

Eligible Conditions
  • Alcoholism

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 6 weeks

2 weeks
Time to raise breath alcohol concentration (BrAC)
6 weeks
Drinking patterns

Trial Safety

Trial Design

2 Treatment Groups

Low frequency repetitive transcranial magnetic stimulation (rTMS)
1 of 2
Sham rTMS Stimulation
1 of 2

Experimental Treatment

Non-Treatment Group

20 Total Participants · 2 Treatment Groups

Primary Treatment: Low frequency repetitive transcranial magnetic stimulation (rTMS) · Has Placebo Group · N/A

Low frequency repetitive transcranial magnetic stimulation (rTMS)Experimental Group · 2 Interventions: Low frequency repetitive transcranial magnetic stimulation (rTMS), Sham · Intervention Types: Device, Device
Sham rTMS StimulationShamComparator Group · 2 Interventions: Low frequency repetitive transcranial magnetic stimulation (rTMS), Sham · Intervention Types: Device, Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sham
2013
Completed Phase 3
~2060

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 weeks

Who is running the clinical trial?

Indiana UniversityLead Sponsor
876 Previous Clinical Trials
749,706 Total Patients Enrolled
6 Trials studying Alcoholism
608 Patients Enrolled for Alcoholism
Michael Francis, MD5.02 ReviewsPrincipal Investigator - Indiana University
Medical School - Indiana University, Doctor of Medicine
Saint Francis Hospital (Residency)
3 Previous Clinical Trials
64 Total Patients Enrolled
5Patient Review
Dr. Teague is very approachable and takes the time to understand my concerns. He is also very helpful, providing information and resources.

Eligibility Criteria

Age 21 - 35 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
) At least 2 occasions of binge drinking in the last 5 weeks (4 or 5 drinks in a day for women and men, respectively)
set The participant is willing and able to adhere to the study schedule set.
is a prerequisite for all clinical research In order to participate in clinical research, you must be able to give informed consent.
Can understand and complete questionnaires and procedures in English.